Hepatitis C Drug Raises Cure Rate in Late Trial - New York Times

[INCIID News Feed]

<img alt="" height="1" width="1" />
Hepatitis C Drug Raises Cure Rate in Late Trial
New York Times
An experimental drug for hepatitis C from Vertex Pharmaceuticals sharply increased the cure rate in a clinical trial, while reducing the time needed for treatment. Experts say the results could herald a new era in treating a sometimes ...
Vertex says hepatitis C drug meets key goalBusinessWeek
Hep C drug achieves 75 percent cure rate: studyReuters
Vertex Reports Strong Late-Stage Hepatitis-C Drug DataWall Street Journal
TheStreet.com -Tech Jackal -RTT News
all 51 news articles &raquo;


More...